Some evidence suggests that resistance to PD‐1 blockade monotherapy in metastatic dMMR CRC is related to lower densities of CD8+ T cells and monocytes in the primary tumors and, that resistant tumors had high expression of IL‐1β with accumulation of immunosuppressive myeloid‐derived suppressor cells [34]. This evidence concerns the gene IL1B and colorectal carcinoma.